Search

Youngest BRCA1 and BRCA2 case ever.

Updated: Aug 6, 2020

February 18, 2016


We are hoping to make this little girl happy. We have our youngest BRCA1 and BRCA2 case ever. She started on our modified amino acid therapy just this month. She is 18 months old. Her mother, her grandmother, aunt and her sister were all positive for BRCA1 and BRCA2. They all tested negative after utilizing our modified amino acid. We know our youngest little girl will prevail just as her relatives have.


Nutritional Science is on the Cutting Edge


Can you imagine a world where disease, illness and human suffering are less?  We can. Discoveries in genetics, epigenetics and biochemistry have allowed the floodgates to open with the very real possibility that many diseases can now be prevented and even reversed with gene-specific nutrient therapy.


Nutrients, not pharmaceuticals, are the fuel that drives all biochemical pathways. The science of the study of nutrients and genetic expression is referred to as “nutrigenomics.” This is the future of medicine.


There now exist a flurry of gene and methylation panel testing which can identify your body’s specific essential nutrient needs. Bypassing mutated genes by supplying missing nutrient substrates in certain methylation pathways will change how all the cells of your body function. Identification of genetic methylation defects may explain so-called “bad genes” or “congenital tendencies.”  Furthermore, due to the paradigm-changing and emerging science of epigenetics and nutrigenomics, there is no further need to assume that inherited genetics or “bad genes” are a death sentence. That paradigm is no longer. 

17 views0 comments

Recent Posts

See All

Second Cancers Caused by CancerTreatment

Advances in radiation therapy and chemotherapy have increased the chances of survival for many people with cancer today. People with cancer are often living longer, so it's becoming more important to